Literature DB >> 834862

Pulmonary alveolar proteinosis: its association with hematologic malignancy and lymphoma.

R Carnovale, J Zornoza, A M Goldman, M Luna.   

Abstract

Pulmonary alveolar proteinosis (PAP) developed in 5 patients with hematologic malignancy or lymphoma. Possible pathogenetic mechanisms which might predispose the patient to this association include the unavailability of competent alveolar phagocytes secondary to profound leukopenia, or inhibition of alveolar phagocytosis by elevated globulins. The spectrum of pulmonary abnormalities produced by PAP includes classical butterfly perihilar alveolar consolidation, lobar consolidation, parenchymal nodules, and hilar adenopathy. Four of the 5 cases had complicating infections, making the exact radiological correlation with PAP difficult.

Entities:  

Mesh:

Year:  1977        PMID: 834862     DOI: 10.1148/122.2.303

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

2.  Degenerative processes in the pathogenesis of pulmonary alveolar lipoproteinosis.

Authors:  D Jacobovitz-Derks; B Corrin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-17

3.  Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Authors:  Eugene Park; Hae-Rim Kim; Hee Joung Kim; Sang-Heon Lee
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

4.  Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

Authors:  T Warner; E Balish
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 5.  Metabolic Functions of the Lung, Disorders and Associated Pathologies.

Authors:  Alcibey Alvarado; Isabel Arce
Journal:  J Clin Med Res       Date:  2016-08-30

Review 6.  Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease.

Authors:  Aashka Parikh; Christopher Vinnard; Nicole Fahrenfeld; Amy L Davidow; Amee Patrawalla; Alfred Lardizabal; Andrew Gow; Reynold Panettieri; Maria Gennaro
Journal:  Int J Environ Res Public Health       Date:  2019-11-01       Impact factor: 3.390

7.  Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction.

Authors:  Aysenur Keske; Eric M Destrampe; Byron Barksdale; William N Rose
Journal:  Case Reports Immunol       Date:  2022-01-30

8.  Pulmonary alveolar proteinosis in association with congenital dyserythropoietic anemia: a case report.

Authors:  Marcus A Carden; Ashish Barman; Gita Massey
Journal:  Case Rep Pediatr       Date:  2012-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.